| Somatic mutations affect key pathways in lung adenocarcinoma L Ding, G Getz, DA Wheeler, ER Mardis, MD McLellan, K Cibulskis, ... Nature 455 (7216), 1069-1075, 2008 | 3129 | 2008 |
| Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines JA Howington, MG Blum, AC Chang, AA Balekian, SC Murthy Chest 143 (5), e278S-e313S, 2013 | 1476 | 2013 |
| Characterizing the cancer genome in lung adenocarcinoma BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ... Nature 450 (7171), 893-898, 2007 | 1287 | 2007 |
| Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study K Shedden, JMG Taylor, SA Enkemann, MS Tsao, TJ Yeatman, ... Nature medicine 14 (8), 822-827, 2008 | 1133 | 2008 |
| International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG) DE Low, D Alderson, I Cecconello, AC Chang, GE Darling, XB D'Journo, ... Annals of surgery 262 (2), 286-294, 2015 | 1049 | 2015 |
| Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity AM Dulak, P Stojanov, S Peng, MS Lawrence, C Fox, C Stewart, S Bandla, ... Nature genetics 45 (5), 478-486, 2013 | 878 | 2013 |
| Non–small cell lung cancer DS Ettinger, W Akerley, G Bepler, MG Blum, A Chang, RT Cheney, ... Journal of the national comprehensive cancer network 8 (7), 740-801, 2010 | 813 | 2010 |
| Non-small cell lung cancer: clinical practice guidelines in oncology DS Ettinger, W Akerley, H Borghaei, AC Chang, RT Cheney, LR Chirieac, ... JNCCN Journal of the National Comprehensive Cancer Network 10 (10), 1236-1271, 2012 | 720* | 2012 |
| Benchmarking complications associated with esophagectomy DE Low, MK Kuppusamy, D Alderson, I Cecconello, AC Chang, G Darling, ... Annals of surgery 269 (2), 291-298, 2019 | 714 | 2019 |
| Two thousand transhiatal esophagectomies: changing trends, lessons learned MB Orringer, B Marshall, AC Chang, J Lee, A Pickens, CL Lau Annals of surgery 246 (3), 363, 2007 | 647 | 2007 |
| Non–small cell lung cancer, version 2.2013 DS Ettinger, W Akerley, H Borghaei, AC Chang, RT Cheney, LR Chirieac, ... Journal of the National Comprehensive Cancer Network 11 (6), 645-653, 2013 | 505 | 2013 |
| Paired exome analysis of Barrett's esophagus and adenocarcinoma MD Stachler, A Taylor-Weiner, S Peng, A McKenna, AT Agoston, ... Nature genetics 47 (9), 1047-1055, 2015 | 382 | 2015 |
| Outcomes after transhiatal and transthoracic esophagectomy for cancer AC Chang, H Ji, NJ Birkmeyer, MB Orringer, JD Birkmeyer The Annals of thoracic surgery 85 (2), 424-429, 2008 | 318 | 2008 |
| Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis X Zheng, M Schipper, K Kidwell, J Lin, R Reddy, Y Ren, A Chang, F Lv, ... International Journal of Radiation Oncology* Biology* Physics 90 (3), 603-611, 2014 | 289 | 2014 |
| Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™ DS Ettinger, G Bepler, R Bueno, A Chang, JY Chang, LR Chirieac, ... JNCCN Journal of the National Comprehensive Cancer Network 4 (6), 548-582, 2006 | 273 | 2006 |
| Circular RNA circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA/AMPKα signaling in STK11 mutant lung cancer X Chen, R Mao, W Su, X Yang, Q Geng, C Guo, Z Wang, J Wang, ... Autophagy 16 (4), 659-671, 2020 | 253 | 2020 |
| Predictors of major morbidity or mortality after resection for esophageal cancer: a society of thoracic surgeons general thoracic surgery database risk adjustment model DP Raymond, CW Seder, CD Wright, MJ Magee, AS Kosinski, SD Cassivi, ... The Annals of thoracic surgery 102 (1), 207-214, 2016 | 249 | 2016 |
| Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model Z Zhang, H Shiratsuchi, J Lin, G Chen, RM Reddy, E Azizi, S Fouladdel, ... Oncotarget 5 (23), 12383, 2014 | 224 | 2014 |
| Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma CT Miller, L Lin, AM Casper, J Lim, DG Thomas, MB Orringer, AC Chang, ... Oncogene 25 (3), 409-418, 2006 | 193 | 2006 |
| Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers V Murlidhar, RM Reddy, S Fouladdel, L Zhao, MK Ishikawa, ... Cancer Research 77 (18), 5194-5206, 2017 | 182 | 2017 |
David G BeerUniversity of MichiganVerified email at umich.edu
